Proceedings: Treatment of acute leukaemia in adults.
D000208:Acute Disease; D000328:Adult; D000493:Allopurinol / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000517:prevention & control; D002648:Child; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007938:Leukemia / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008659:Metabolic Diseases / Q000517:prevention & control; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013866:Thioguanine / Q000627:therapeutic use; D014527:Uric Acid / Q000097:blood; D014750:Vincristine / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D003561:Cytarabine; D014527:Uric Acid; D014750:Vincristine; D000493:Allopurinol; D013866:Thioguanine; D011241:Prednisone; D006918:Hydroxyurea; D003630:Daunorubicin